que es la tirzepatide Qué es el Tirzepatide y por qué está causando tanto “revuelo”?

In the SURPASS CVOT head to head trial involving over 13,000 adults with T2D and ASCVD, tirzepatide (Mounjaro) matched dulaglutide in reducing major cardiovascular events (8% lower risk) and significantly cut all cause mortality by 16%. Semaglutide vs Tirzepatide: How to Decide Which Is Best for You 1 How much weight do you want to lose? Mild to moderate weight loss? Semaglutide (average 1215%) Significant weight Patients who took the anti obesity drug tirzepatide for almost two years lost 25 percent of their body weight and maintained improvements in metabolic and cardiovascular health, according to a new phase 3 Course of nausea with semaglutide. GLP 1RA, including semaglutide, Download Scientific Diagram Compounded Tirzepatide The IV Lounge Low Dose Tirzepatide: Clinical Dosing & Biomarker Insights PlexusDx